Latest SEC Filings

WATERS CORP /DE/Waters Corporation Reports $1.267 Billion Revenue and $72 Million Net Loss Following BDS Acquisition

INTELLIGENT PROTECTION MANAGEMENT CORP.Intelligent Protection Management Corp. Reports $6.35M Revenue with 15.2% Growth in Q1 2026

Hyliion Holdings Corp.Hyliion Reports 479% Revenue Increase and Reduced Net Loss in Q1 2026

Atara Biotherapeutics, Inc.Atara Biotherapeutics Reports Significant Revenue Decline and Net Loss in Q1 2026

TherapeuticsMD, Inc.TherapeuticsMD Reports Net Income of $95,000 in Q1 2026, Revenue Up 84%

Intellicheck, Inc.Intellicheck Reports 13% Revenue Growth and Net Income Turnaround in Q1 2026

Lineage Cell Therapeutics, Inc.Lineage Cell Therapeutics Reports 15% Revenue Growth in Q1 2026

Fold Holdings, Inc.Fold Holdings Reports $29.2 Million Net Loss, Launches New Credit Card and Bitcoin Bonus Program

Paramount Gold Nevada Corp.Paramount Gold Nevada Corp. Reports Increased Net Loss and Asset Growth for March 2026

Verrica Pharmaceuticals Inc.Verrica Pharmaceuticals Reports $5.0 Million Revenue in Q1 2026, Net Loss of $9.7 Million

Cyclerion Therapeutics, Inc.Cyclerion Therapeutics Reports $3.2 Million Net Loss in Q1 2026, Plans Merger with Korsana Biosciences

Kura Oncology, Inc.Kura Oncology Reports $18.3 Million Revenue in Q1 2026, Net Loss Increases to $73.3 Million

Evolv Technologies Holdings, Inc.Evolv Technologies Reports 45% Revenue Growth to $46.3 Million in Q1 2026

STRATUS PROPERTIES INCStratus Properties Reports Q1 2026 Financial Turnaround with $6.6M Net Income

Zentalis Pharmaceuticals, Inc.Zentalis Pharmaceuticals Reports $35.4 Million Net Loss in Q1 2026, Announces Phase 3 Trial for Azenosertib

D-Wave Quantum Inc.D-Wave Quantum Inc. Reports 81% Revenue Decline and Expands Through Acquisition

AramarkAramark Reports 14.7% Revenue Growth to $4.91 Billion in Q2 Fiscal 2026

ZEBRA TECHNOLOGIES CORPZebra Technologies Reports 14.3% Revenue Growth to $1.495 Billion in Q1 2026

Hyperfine, Inc.Hyperfine Reports 83% Revenue Growth to $3.9 Million in Q1 2026

Immunome Inc.Immunome Reports $53.8 Million Net Loss in Q1 2026, Cash Reserves Decline

Hour Loop, IncHour Loop, Inc. Reports 15.8% Revenue Growth to $29.93 Million in Q1 2026

Maze Therapeutics, Inc.Maze Therapeutics Reports $20 Million License Revenue and $24.2 Million Net Loss in Q1 2026

Electromed, Inc.Electromed, Inc. Reports 18.4% Revenue Growth to $18.575 Million in Latest Quarter

Nkarta, Inc.Nkarta Reports Q1 2026 Financial Results with $27.8 Million Net Loss

IZEA Worldwide, Inc.IZEA Worldwide Reports 18% Revenue Decline and Increased Losses in Q1 2026